The level of tau protein increases in the blood and CSF in several neurodegenerative conditions (tauopathies), including AD, frontotemporal dementia (FTD), PD and LBD, amyotrophic lateral sclerosis, and prion disease [30, 39, 40]. Here, MAPT is linked to Alzheimer disease.